Month: March 2023

TORONTO, March 30, 2023 (GLOBE NEWSWIRE) — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that the Company has filed its management information circular (“Circular”) and related materials (together with the Circular, the “Meeting Materials”) for the annual and special meeting of shareholders (the “Shareholders”) of Jamieson Wellness to be held on May 18, 2023 at 2:00 p.m. (Eastern Daylight Time) at the offices of McCarthy Tetrault LLP, 66 Wellington Street West, Toronto, Ontario, Suite 5300, and online via live audio webcast at https://meetnow.global/MMUNSXJ (the “Meeting”). The Company is pleased to be offering Shareholders the option to participate in-person at this year’s Meeting, while continuing to offer Shareholders the option to participate online via live audio webcast. The Meeting...

SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) — OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Artificial Intelligence (AI) and IoT – based solutions announces record breaking revenue with Full Year 2022 of $102.5M an all-time high and a Q4 of $25M.  ● Record Revenue of $102.5 Million a 31% YoY increase       ● Record Gross Profit of $22.1 Million an increase of $5.4 Million or 33% over FY 2021       ● Positive Cash Flow from Operations of $1.2 Million compared to a deficit of $3.2M in FY 2021       ● AI Machine Vision Revenue increased by more than 100% compared to FY 2021 driven by strong customer demand across Public Safety, Automation of Parking and Retail and Quick Service Restaurants       ● Company completed the acquisition of 100% of Dangot Computers Ltd., a leader in providing...

PLANO, Texas, March 30, 2023 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), an emerging healthy snack and eating platform disrupting traditional consumer packaged goods (CPG) categories, and a leader in the air-dried meat snack industry in the United States, today announces that it will release its fiscal 2022 fourth quarter and full year results on Monday, April 3, 2023, before the market opens, and host a conference call on that same day at 9:00am ET. In addition to a discussion around 2022 performance, management will provide fiscal 2023 guidance for select financial measures, an overview of its capital plans, as well as commentary regarding meaningful distribution wins, as a result of, improvements in product quality, its retail strategy, and brand positioning that are expected to support...

TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that three additional detailed analyses from the Phase IIb clinical study (Study 201), evaluating the efficacy and safety of lecanemab for mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD), were published in the peer-reviewed journals.Detailed results on biomarker, cognitive, and clinical effects from Study 201 core to OLE (open-label extension): Alzheimer’s Research and Therapy Consistency of efficacy results across various clinical measures and statistical methods in Study 201:...

TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai presented new analyses on amyloid-related imaging abnormalities (ARIA) with the use of antiplatelet and anticoagulant medications, isolated ARIA-H, and caregiver burden and health-related quality of life (QOL), from the results of Eisai’s Phase 3 Clarity AD study of lecanemab (generic name, U.S. brand name: LEQEMBI™), an anti-amyloid-β (Aβ) protofibril* antibody, at the 2023 International Conference on Alzheimer’s and Parkinson’s Diseases annual meeting AD/PD™. Clarity AD was a global confirmatory Phase 3 placebo-controlled,...

DENVER, March 30, 2023 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, provides a business update and reports financial results for the year ended December 31, 2022. “We are focusing on executing near-term milestones that will advance our business,” said Eric Schlorff, SeaStar Medical CEO. “Our immediate efforts are aimed at raising awareness with the medical community of our cell-directed extracorporeal therapy’s potential for playing a life-saving role for critically ill patients, working with regulators to bring products to market, and ensuring we have the systems and processes in place to serve market needs.” BUSINESS UPDATE SeaStar Medical provides...

Confirms Vision to Power the Energy Transition Through Innovation in Critical Minerals VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”), is pleased to announce completion of an internal strategic review of the Company’s technologies, commercial opportunities, and challenges conducted by the Company’s leadership team appointed in late 2022. Medallion’s vision is to power the energy transition through innovation in critical minerals by becoming an owner-operator of critical mineral processing facilities in partnership with upstream feedstock and downstream offtake partners. The first step towards delivering that vision is to establish a commercially-oriented magnetic rare earth evaluation facility deploying patented...

HARTSVILLE, S.C., March 30, 2023 (GLOBE NEWSWIRE) — Sonoco Products Company (NYSE: SON), a diversified global packaging company recognized for its leadership in sustainability, today announced it has sold approximately 55,000 acres of timberlands in South Carolina for $72 million in cash to Manulife Investment Management (Manulife IM) on behalf of its clients. Manulife IM is a timberland and agricultural investment manager which sustainably manages approximately 6 million acres around the globe.  Sonoco Chief Executive Officer Howard Coker said, “Today, Sonoco produces paper exclusively from recycled fibers and no longer requires natural tree fiber for production. Through this sale, we are pleased to have the opportunity to maximize value for our shareholders while also ensuring that the property goes to a buyer that puts sustainable...

Key Deal Terms:NOVONIX Limited (“NOVONIX”) and TAQAT Development Company (“TAQAT”) have agreed to form an incorporated Joint Venture (JV) in the Kingdom of Saudi Arabia to produce high-performance graphite anode for use in electric vehicle (“EV”) and energy storage system (“ESS”) applications. It is intended that the JV will undertake engineering for the facility in its first year with the target to begin facility construction in 2024. NOVONIX will contribute access on a royalty-free basis to its proprietary intellectual property to the JV for the production and sales of high-performance graphite anode in the Middle East and North Africa (“MENA”) region. TAQAT will hold a 60 percent equity stake in the JV vehicle and NOVONIX will hold a 40 percent stake with each party contributing their share of operating and capital costs for engineering...